Targeting P-selectin blocks neuroblastoma growth.

Nolo, Riitta; Herbrich, Shelley; Rao, Arvind; Zweidler-McKay, Patrick; Kannan, Sankaranarayanan; Gopalakrishnan, Vidya

Nolo, Riitta; Herbrich, Shelley; Rao, Arvind; Zweidler-McKay, Patrick; Kannan, Sankaranarayanan; Gopalakrishnan, Vidya.

Afiliação

Nolo R; Departments of Pediatrics, M.D. Anderson Cancer Center, Houston, TX, USA.
Herbrich S; Departments of Pediatrics, M.D. Anderson Cancer Center, Houston, TX, USA.
Rao A; Bioinformatics and Computational Biology, M.D. Anderson Cancer Center, Houston, TX, USA.
Zweidler-McKay P; Departments of Pediatrics, M.D. Anderson Cancer Center, Houston, TX, USA.
Kannan S; ImmunoGen Inc., Waltham, MA, USA.
Gopalakrishnan V; Departments of Pediatrics, M.D. Anderson Cancer Center, Houston, TX, USA.

Oncotarget ; 8(49): 86657-86670, 2017 Oct 17.

Article em En | MEDLINE | ID: mdl-29156825

Palavras-chave

CyTOF; P-selectin; neuroblastoma; selectin inhibition; tumor heterogeneity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article